Mavatar Discovery

Sign up for Mavatar

Discovery™ beta

Be the first to experience Mavatar Discovery‍
Our first Saas-platform, Mavatar Discovery, is launching soon—and it’s a game-changing self-service platform designed for pharmaceutical companies, CRO’s, researchers, and academia.

Go to the sign up form

We're opening our first beta program in April!

Right now, we’re gathering interest from those who want early and free access to explore how our platform unlocks deep, integrated network analysis on all disease mechanisms—genes, cells, and signaling pathways—using vast amounts of public and proprietary OMIC data.


What makes Mavatar Discovery different?

· A complete, ready-to-use solution – No complex setup, just powerful, actionable ready to use insights that will speed up your research, study or drug development process.
· All-Inclusive data integration – Combine public datasets with your own research.
· Breakthrough analytics – Discover trends, biomarkers, and drug development opportunities with unparalleled depth.


What do you get?

A large-scale integrated resource that provides data-driven, actionable insights that immediately impact your research and development. (Instead of thousands of different datasets that you need to continue to analyze yourself).


Why register your interest?

· Get exclusive early and free access – Be among the first to test Mavatar Discovery.
· Revolutionize your research – Gain curated, data-driven insights that accelerate discoveries.
· Help shape the future – Provide feedback and influence the final platform.


Sign up today to express your interest in joining the beta.

We’ll be in touch soon to confirm if you’ve been selected.
Beta testing begins in mid-April—get ready to explore the future of data-driven research!
Spots are limited! Sign up now to express your interest, and we’ll be in touch soon.